Hefei National Laboratory for Physical Sciences at Microscale and Department of Neurobiology, School of Life Sciences, University of Science & Technology of China, 443 Huangshan Road, Hefei, Anhui 230027, People's Republic of China.
Neurosci Lett. 2010 Jan 18;469(1):112-6. doi: 10.1016/j.neulet.2009.11.055. Epub 2009 Nov 26.
TAR DNA-binding protein-43 (TDP-43) is a nuclear protein functioning in the regulation of transcription and mRNA splicing. TDP-43 is accumulated in ubiquitinated inclusions in frontotemporal lobar degeneration with ubiquitin-positive inclusions (FTLD-U) and amyotrophic lateral sclerosis (ALS) diseased brains. However, the pathways involved in the clearance of TDP-43 and its pathogenic form (TDP-25), a truncated form of TDP-43, are still not elucidated. In this study, we demonstrated that the protein levels of TDP-43 and TDP-25 were increased in cells treated with a proteasome inhibitor, MG132, or an autophagy inhibitor, 3-MA, whereas, they were decreased in cells treated with an enhancer of autophagy, trehalose. Furthermore, more protein level changes of TDP-25 than TDP-43 were observed in cells treated with above inhibitors or enhancer. Thus, our data suggest that TDP-43 and TDP-25 are degraded by both proteasome and autophagy with TDP-25 being more regulated.
TAR DNA 结合蛋白-43(TDP-43)是一种核蛋白,在转录和 mRNA 剪接的调节中发挥作用。TDP-43 在额颞叶变性伴泛素阳性包涵体(FTLD-U)和肌萎缩侧索硬化症(ALS)病脑中积聚于泛素阳性包涵体中。然而,TDP-43 及其致病性形式(TDP-25)的清除途径仍未阐明。在这项研究中,我们证明了用蛋白酶体抑制剂 MG132 或自噬抑制剂 3-MA 处理的细胞中 TDP-43 和 TDP-25 的蛋白水平增加,而用自噬增强剂海藻糖处理的细胞中则降低。此外,在用上述抑制剂或增强剂处理的细胞中,TDP-25 的蛋白水平变化比 TDP-43 更为明显。因此,我们的数据表明 TDP-43 和 TDP-25 均可通过蛋白酶体和自噬降解,而 TDP-25 的调节更为复杂。